written on 13.05.2014
Tags:
,

Industry Selects the Biopharmaceutical Deal of the Year

TAGS: ,

Deal of the Year winners were announced in the partnering and M&A categories at the Thomson Reuters Allicense 2014 meeting Tuesday April 29th. From a short list of five deals industry selected the partnership involving Biogen Idec Inc. and Isis Pharmaceuticals Inc. whose goal is to apply antisense technology to the discovery and development of […]

Latest Report